Jeffrey A. Bailey - 18 Aug 2023 Form 3 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ Jeffrey A. Bailey
Issuer symbol
AUPH
Transactions as of
18 Aug 2023
Net transactions value
$0
Form type
3
Filing time
21 Aug 2023, 17:21:53 UTC
Previous filing
22 Mar 2022
Next filing
12 Nov 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.